Jill McGill, professional golfer and champion of the 2022 U.S. Senior Women’s Open, spoke to reporters at this year’s tournament about her personal connection to the ovarian cancer cause. “When you have people that close to you, it really makes you want to make a difference, not only in their lives, but in the future … Continued
As we gear up for Ovarian Cancer Awareness Month, we are turning our attention to two OCRA Heroes who are harnessing the power of everyday technology to garner support for our community and educate others about ovarian cancer via online fundraising campaigns for OCRA. Read on to learn more about their stories and the inspiring … Continued
A recent article from Stat News reports that as the United States continues to face a concerning shortage of vital chemotherapy drugs, ovarian cancer patients are among the hardest hit. According to Stat News, nearly 93% of U.S. cancer centers are reporting shortages of carboplatin, which is the most common first-line treatment for ovarian cancer. … Continued
Dr. Benjamin Bitler of the University of Colorado is a 2022 recipient of OCRA’s Collaborative Research Development Grant. His OCRA-funded project, which is expanding on findings from the Ovarian Cancer Research Group at the University of Colorado, aims to harness cutting-edge molecular profiling and advanced computational analysis in order to predict ovarian cancer recurrence and provide … Continued
In a profile with Westfair Business Journal, OCRA’s President & CEO Audra Moran speaks about her background, the direction of ovarian cancer research and prevention, and how OCRA’s programs are moving the needle forward. Read the full article, “Unlocking the secrets of ovarian cancer,” written by Georgette Gouveia and published on August 4, 2023.
September is the official month for Ovarian Cancer Awareness. Ovarian Cancer Awareness Month is our time to spread the word about risk and prevention, rally for more scientific research, and make progress toward a cure. Read on for ways you can be an ambassador for Ovarian Cancer Awareness Month! Here’s how you can make a … Continued
No, a Pap smear does not test for ovarian cancer; it screens for cervical cancer. In fact, no reliable screening or early detection tests exist for ovarian cancer. What is a Pap Smear? In the realm of women’s health, a prevalent question emerges: “Does a Pap smear reveal ovarian cancer?” This inquiry stems from a … Continued
OCRA-Funded Study Targets Immunotherapy OCRA grantees and their Roswell Park Comprehensive Cancer Center colleagues published results from an exciting study detailing a new approach to adoptive T-cell therapy that may help improve immunotherapy options for ovarian cancer patients. Learn more about the findings from the research team, which included Dr. Bob McGray, OCRA grantee, and Dr. Kunle Odunsi, … Continued
A recent study from Cancer Nursing has shed more light on the profound impact gynecologic cancer has on survivors, even after treatment. In particular, the study highlighted the prevalence of fear of recurrence among gynecologic cancer survivors, regardless of their prognosis, and underscores the importance of support programs to address survivors’ needs adequately. Through in-depth … Continued
Dr. Chi Lam Au Yeung of the University of Texas MD Anderson Cancer Center is a 2022 recipient of OCRA’s Early Career Investigator Grant. Her OCRA-funded project is focused on studying molecules produced by ovarian cancer cells in order to gain new insights into the interrelationship between different cell types in the progression of this … Continued
Two groups of golf aficionados are stirring up some playful competition this summer to raise funds for a serious cause: ovarian cancer research. And though their charity tournaments are separate from each other, both groups of OCRA Heroes had the same motivation to give back to the ovarian cancer community. They were moved by incredible … Continued
Fewer people each year are being diagnosed with ovarian cancer. Why do you feel the numbers are decreasing? OCRA’s Scientific Advisory Committee (SAC) is composed of doctors and researchers who are well-known and well-respected experts in the field of gynecologic oncology. They review the proposals we receive for research funding — hundreds of letters of … Continued
Get email updates about research news, action alerts, and ways to join the fight.
